Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot#GS-US-419-3895: Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease
Hanauer, stephen B
(PD/PI)
Medicine, Gastroenterology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
7/19/17
→
7/19/24
Funding
Gilead Sciences, Inc
(Prot#GS-US-419-3895)
View all
View less